Healthcare provider profile · identity verified

Maureen Patricia Andreassi, M.D.

Internal Medicine · MATTHEWS, NC · NPI 1669413332

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	973	290
Amlodipine Besylate	Amlodipine Besylate	775	213
Rosuvastatin Calcium	Rosuvastatin Calcium	533	157
Levothyroxine Sodium	Levothyroxine Sodium	475	130
Losartan Potassium	Losartan Potassium	396	109
Lisinopril	Lisinopril	325	89
Omeprazole	Omeprazole	221	69
Alendronate Sodium	Alendronate Sodium	216	70
Ezetimibe	Ezetimibe	183	58
Metoprolol Succinate	Metoprolol Succinate	183	52
Hydrochlorothiazide	Hydrochlorothiazide	154	55
Metformin Hcl Er	Metformin Hcl	153	50
Gabapentin	Gabapentin	149	47
Pravastatin Sodium	Pravastatin Sodium	144	45
Pantoprazole Sodium	Pantoprazole Sodium	138	39
Trazodone Hcl	Trazodone Hcl	117	35
Jardiance	Empagliflozin	114	30
Duloxetine Hcl	Duloxetine Hcl	110	29
Valsartan	Valsartan	110	32
Metformin Hcl	Metformin Hcl	103	31
Allopurinol	Allopurinol	100	26
Simvastatin	Simvastatin	99	32
Escitalopram Oxalate	Escitalopram Oxalate	97	31
Famotidine	Famotidine	95	31
Mirtazapine	Mirtazapine	91	27
Furosemide	Furosemide	84	28
Atenolol	Atenolol	79	19
Montelukast Sodium	Montelukast Sodium	79	24
Citalopram Hbr	Citalopram Hydrobromide	78	28
Fluticasone Propionate	Fluticasone Propionate	77	35
Bupropion Xl	Bupropion Hcl	73	16
Sertraline Hcl	Sertraline Hcl	72	24
Eliquis	Apixaban	69	20
Synthroid	Levothyroxine Sodium	68	21
Potassium Chloride	Potassium Chloride	64	17
Buspirone Hcl	Buspirone Hcl	63	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	21
Carvedilol	Carvedilol	57	17
Metoprolol Tartrate	Metoprolol Tartrate	57	13
Tamsulosin Hcl	Tamsulosin Hcl	56	19
Donepezil Hcl	Donepezil Hcl	50	17
Clopidogrel	Clopidogrel Bisulfate	48	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	18
Farxiga	Dapagliflozin Propanediol	43	suppressed
Finasteride	Finasteride	43	12
Memantine Hcl	Memantine Hcl	43	suppressed
Raloxifene Hcl	Raloxifene Hcl	43	13
Fluoxetine Hcl	Fluoxetine Hcl	42	13
Ropinirole Hcl	Ropinirole Hcl	42	13
Hydroxyzine Hcl	Hydroxyzine Hcl	40	12
Tramadol Hcl	Tramadol Hcl	39	16
Alprazolam	Alprazolam	38	14
Ramipril	Ramipril	38	12
Albuterol Sulfate Hfa	Albuterol Sulfate	37	17
Baclofen	Baclofen	34	14
Meloxicam	Meloxicam	34	11
Ozempic	Semaglutide	31	11
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Pregabalin	Pregabalin	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	23
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	16
Triamcinolone Acetonide	Triamcinolone Acetonide	23	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Mounjaro	Tirzepatide	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Nitroglycerin	Nitroglycerin	18	16
Benazepril Hcl	Benazepril Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clonidine	Clonidine	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Rivastigmine	Rivastigmine	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Risperidone	Risperidone	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cephalexin	Cephalexin	12	11
Clonazepam	Clonazepam	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Risedronate Sodium	Risedronate Sodium	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error